Welcome to the Australian Bio Directory

⠀
Search by company name, service category, contact name and more...
Search by location
208 Results found
All Categories
New South Wales
MINIMUM bio
Australia
MINIMUM bio specializes in accelerating drug target identification for the pharmaceutical industry, aiming to enhance drug discovery processes and reduce the time and costs associated with preclinical research and development. We specialise in the discovery of molecular glues and new drug targets.
Company Type (Public/Private)
Working with:
Contact person(s):
Year founded
2022
No of Employees
2-6
Visit Profile
Queensland
Resolian Bioanalytics
Australia and 1 other(s)
Resolian is a global laboratory contract research organization that provides bioanalytical and analytical sciences support for drug development, preclinical, and multi-regional clinical trials, emphasizing exceptional solutions and strong collaborative relationships. The company offers services in drug metabolism and pharmacokinetics and bioanalytical, new drugs, metabolites or generic drug assays, large molecule immunoassays, small molecule metabolite profiling and identification and biosimilar characterization, thereby assisting clients through the process of taking a drug from pre-clinical trials to market at earliest.
Company Type (Public/Private)
Working with:
Contact person(s):
Year founded
2007
No of Employees
20-600
Visit Profile
Victoria
CBE Pure Solutions
Australia
CBE Pure Solutions (CBEPS) is an Australian based Contract Manufacturing Organisation (CMO), supporting Biotech and Pharmaceutical companies in the translation of Life Science products. Specialising in sterile fill and finish and microbiological testing.Established 2021, CBEPS expertise lies in providing fill and finish services and microbiological testing services. CBEPS operate a state-of-the-art facility in Melbourne’s South East Biotech precinct, designed for Good Manufacturing Practice (cGMP) compliance and international standards. The company specialises in fill and finish services for liquid medicinal products and medical devices, offering comprehensive monitoring and testing services, including environmental monitoring and sterility testing.The Clinical trial facility is Australia's only contract manufacturing facility utilising isolator technology for small scale boutique filling of specialist advanced therapy and traditional small molecule products with capability of vials and syringes from 1ml to 20ml. Licensing for Phase 2 and 3 clinical trials is anticipated in June, 2025.The facility works to cGMP across all modules and holds TGA accreditation for laboratory testing and Quality systems (Licence MI-2023-08205-1) and Animal Health APVMA (Licence 1126).
Company Type (Public/Private)
Working with:
Contact person(s):
Languages
English
Year founded
2021
No of Employees
9-12
Visit Profile
New South Wales
Celosia Therapeutics
Australia
Celosia Therapeutics is an innovative biotech startup dedicated to developing cutting-edge genetic medicines for neurodegenerative diseases, with a primary focus on Amyotrophic Lateral Sclerosis (ALS) and Dementia (Alzheimer’s & FTD). Our mission is to provide transformative treatment options to patients with limited therapeutic alternatives.
Advanced therapies including cell & gene
Working with:
Contact person(s):
Year founded
2022
Visit Profile
Global Pharma Solutions
Australia and 1 other(s)
Global Pharma Solutions (GPS): Experienced professionals accelerating medicine registrations globally. GPS is a global regulatory and product development consulting firm with experts in both the US and Australia. We have over 22 years’ experience in developing and registering hundreds of products including small molecules, biologics and medical devices and 11 years’ experience with cell and gene therapies, particularly liaising with the FDA.We guide biotech companies through complex development pathways, ensuring a clear route to market approval.Through our partner CROs, we also offer support with clinical operations.
Company Type (Public/Private)
Working with:
Contact person(s):
Year founded
2003
No of Employees
5-11
Visit Profile
Government of NSW, Australia
Australia and 1 other(s)
New South Wales is an economic powerhouse, boasting Australia’s largest economy, at A$643 billion - the 12th largest in the world. More than 600 multinational companies have their regional headquarters in Sydney, and many of Australia’s largest venture capital firms are headquartered here.NSW has Australia’s largest population, with 8.2 million residents. More than two-thirds of the population hold post-school qualifications. NSW is home to the highest number of STEM graduates in the country and is a top ranked start-up ecosystem in the southern hemisphere.The NSW public health system is the largest in Australia and one of the best in the world. It benefits from being well connected; world-leading public healthcare is delivered through 228 public hospitals managed by 15 local health districts and two speciality networks, all supported by centralised policy and support pillars.The state is home to globally significant Health and Innovation Precincts, which provide distinguished crossroads of medicine, science, education, and industry.
Government
Working with:
Contact person(s):
Year founded
1856
Visit Profile
New South Wales
Obatica Oncology & Medical
Australia
Obatica Oncology & Medical is a boutique medical focused drug development and clinical trial consultancy firm. Obatica services includes clinical development strategy, & commercialisation, clinical trial study design, medical writing, medical monitoring, and pharmacovigilance.Specialising in complex early phase clinical trials in Oncology, Rare Diseases, Allergy, Pain and other therapeutic areas. Our development experience includes small molecules, monoclonal antibodies, RNA-based therapies, cell therapies and radiotheranostics. Our advice has been tried-and-proven to save time and unnecessary costs.Obatica is also a leading Medical and clinical trial Functional Service Provider (FSP) with our Australian-trained and practicing clinicians with clinical trials experience, providing senior medical director or sponsor medical representative roles. Our in-house specialist doctors include Medical Oncologists, General Medicine Physicians, Geriatricians, and General and specialty Surgeons to support your project. Let’s have a free initial confidential chat about your drug development or clinical trial project.
Clinical Trial Management and Support
Working with:
Contact person(s):
Languages
English
Year founded
2021
No of Employees
5-10
Visit Profile
New South Wales
Ascend CRO
Australia and 3 other(s)
With nearly 40 years of experience serving leaders in medical device technology, our team is dedicated to lifting every aspect of your trial, from early protocol design to speedy approvals, data monitoring & collection and beyond. We combine an Australia-based CRO foundation with global reach, and CRC's available across Australia, New Zealand, & Asia, ensuring we meet the requirements for US FDA Clinical Trials, European CE mark and other international regulations.
Contact Research Organisation (CRO)
Working with:
Contact person(s):
No of Employees
10-20
Visit Profile
South Australia
Clever Culture Systems
Australia and 2 other(s)
Clever Culture Systems (ASX: CC5) is an Australian biotechnology leader developing AI-powered microbiology solutions. Their flagship product, the Automated Plate Assessment System (APAS), addresses a critical global challenge in pharmaceutical manufacturing where millions of culture plates are manually processed yearly. APAS uses patent-protected machine learning and intelligent imaging to automate the interpretation and reporting of microbial growth on culture plates, supporting the sterility and compliance requirements for safe production of drugs. Following a decade of development, Clever Culture Systems launched APAS® in 2024. Major pharmaceutical companies including AstraZeneca, Bristol Myers Squibb, and CDMO such as Thermo Fisher Scientific have adopted APAS. With blue-chip customers in place and additional sales completed, there is a substantial market opportunity for APAS® to become the new standard in pharmaceutical microbiology automation.
Company Type (Public/Private)
Working with:
Contact person(s):
Visit Profile
Queensland
VenturePro
Australia
Advisor at the intersection between life sciences, healthcare innovation and sustainable development, specialising in ecosystem development and building national and international research partnerships and collaborations. A track record of securing over $2.4 billion in funding for transformative initiatives from biomedical precincts and hubs such as the Herston Health Precinct, to environmental programs like the $450m Reef Trust Partnership - projects that deliver lasting social, economic and environmental impact.I'm particularly interested in the design of healthcare and innovation precinct environments such that they are inclusive, accessible and flexible, and anticipate evolving societal and end-user needs. Working with healthcare leaders, placemaking experts, urban planners and arts and cultural programmers and designers, I explore how healthcare and research districts can better integrate with their surroundings to create engaging spaces where science, creativity, and community intersect.I focus on:Developing and activating innovation precincts and ecosystemsBuilding complex multi-stakeholder partnershipsTranslating research into real-world impactCreating governance frameworks for sustainable collaborationSupporting investment in transformative initiativesBeyond my commercial work, I serve as Director for Micah Projects Ltd, supporting their mission to secure foundational human rights. My work is guided by a commitment to creating sustainable, inclusive, and vibrant places where innovation thrives and communities benefit.
Company Type (Public/Private)
Working with:
Contact person(s):
Year founded
2005
No of Employees
1-4
Visit Profile
View all Companies
Showing 1-10 of 208 results
.....